Nitroglycerin-aggravated pre-eclamptic posterior reversible encephalopathy syndrome (PRES)
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In rare cases, eclampsia, defined as perinatal seizures in pre-eclampsia (hypertension, >140/90 mm Hg; proteinuria, >1+ qualitatively; edema, >20th week of gestation),1 is associated with the posterior reversible encephalopathy syndrome (PRES).2 PRES is attributed to a vasogenic edema of unknown pathomechanism in the posterior circulation territories.3 Whether the vasodilator nitroglycerin aggravates the edema in patients with eclamptic PRES is unknown.
Case report.
A 27-year-old woman, gravida 2, para 1, developed pre-eclampsia at week 35 of gestation. The history for hypertension, renal insufficiency, and paternity change was negative. Prepregnancy blood pressure was 120/85 mm Hg. Elevated blood pressure at week 36 of gestation prompted hospitalization (blood pressure on admission, 170/120 mm Hg) and, because of intractability, urgent cesarean section on hospital day 5 (presurgery blood pressure, 156/112 mm Hg). Six hours after cesarean section, she developed diffuse headache, associated with blood pressure values up to 177/115 mm Hg. For hypertension she received urapidil and metoprolol, with minimal effect. On hospital day 6, diffuse headache recurred, and because blood pressure was 177/119 mm Hg, 2 heaves of nitroglycerin (0.8 mg) were given …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Posterior leukoencephalopathy without severe hypertensionUtility of diffusion-weighted MRIH. Ay, F. S. Buonanno, P. W. Schaefer et al.Neurology, November 01, 1998 -
Articles
Status epilepticus as initial manifestation of posterior reversible encephalopathy syndromeO. S. Kozak, E.F.M. Wijdicks, E. M. Manno et al.Neurology, August 27, 2007 -
Article
Early postmortem brain MRI findings in COVID-19 non-survivorsTim Coolen, Valentina Lolli, Niloufar Sadeghi et al.Neurology, June 16, 2020 -
Articles
Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disordersS. M. Magaña, M. Matiello, S. J. Pittock et al.Neurology, February 23, 2009